119th Congress
S. 3751
Prescription Drug Supply Chain Pricing Transparency Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Michael F. Bennet(D-CO)
- Introduced
- Jan 29, 2026
- Policy area
- Health
- Committees
- Senate Committee on Finance
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (1)
Original cosponsors (1)
- James Lankford (R-OK)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Latest action(Jan 29, 2026): Read twice and referred to the Committee on Finance.
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 29, 2026 · Senate
Read twice and referred to the Committee on Finance. - Jan 29, 2026
Introduced in Senate